首页> 外文期刊>Asian Journal of Chemistry: An International Quarterly Research Journal of Chemistry >Stability Indicating Method Development and Validation of Finasteride by High-Performance Thin-Layer Chromatography Studies
【24h】

Stability Indicating Method Development and Validation of Finasteride by High-Performance Thin-Layer Chromatography Studies

机译:高性能薄层色谱研究的稳定性指示方法开发和验证

获取原文
获取原文并翻译 | 示例
       

摘要

The present research work determines the stability of finasteride by forced degradation studies. Finasteride was treated with hydrolytic stressors such as acid, alkali and neutral stress, further finasteride was also treated with oxidative, photolytic and thermal stress conditions. Method development, validation and separation of the degradation products for the drug were carried out by using high-performance thin-layer chromatographic system (HPTLC). The drug was found to degrade under basic and oxidative stress conditions. The mobile phase composition for HPTLC analysis consisted of chloroform-methanol (8:2 % v/v). The UV spectrophotometry spectra of finasteride showed λ_(max) at 210 nm; hence this wavelength was chosen for densitometric analysis. The R_F value for finasteride was found to be 0.57 with a compact spot. The method was validated as per ICH guidelines Q2(R 1) and good linear relationship was observed in the concentration range of 200-1400 ng band~(-1). Percent recovery for the drug was within limit and was found to be in the range of 98.52-99.66 %. For precision studies the % relative standard deviation (% RSD) was < 1.5 %. The developed HPTLC method has been successfully applied for the analysis of finasteride in tablet dosage form.
机译:目前的研究工作通过强制降解研究决定了三维媒介的稳定性。用水解胁迫器如酸,碱和中性应激处理过亚甾醇,还通过氧化,光解和热应力条件处理进一步的过滤器。通过使用高性能薄层色谱系统(HPTLC)进行药物降解产物的方法开发,验证和分离。发现该药物在碱性和氧化胁迫条件下降解。 HPTLC分析的流动相组合物由氯仿 - 甲醇(8:2%v / v)组成。聚光剂的紫外分光光度法谱显示为210nm的λ_(max);因此,选择该波长用于密度计量分析。 FINASTIDE的R_F值被发现为0.57,具有紧凑的点。根据ICH指南验证该方法,在200-1400ng带〜(-1)的浓度范围内观察到良好的线性关系。药物的百分比率在限制范围内,发现在98.52-99.66%的范围内。对于精确研究,%相对标准偏差(%RSD)<1.5%。已成功地应用于开发的HPTLC方法用于分析片剂剂型中的三甾体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号